A poignant national touring exhibition, born from a mother's grief for her son Oscar Grant, uses birthday remembrances to humanize victims of police brutality and examine the enduring impact on communities.
A major human rights review accuses the Labour government of eroding civil liberties through expansive surveillance, restrictive protest laws, and the controversial banning of activist groups, raising alarms about the state of democracy in Britain.
The UN children's agency is urging nations worldwide to outlaw the creation of AI-generated child sexual abuse material, citing alarming reports of a surge in such fabricated content. The call comes as Britain moves to become the first country to explicitly criminalize the practice.
As reproductive rights face escalating legal threats, personal finance experts are advising clients to prioritize dedicated savings for abortion access—a stark reflection of America's shifting healthcare landscape.
Novo Nordisk reports unprecedented early uptake of its oral Wegovy, with weekly prescriptions hitting 50,000 within weeks of its U.S. debut. The pill's lower price and convenience are broadening access to GLP-1 treatments amid a rapidly evolving market.
Enphase Energy's latest quarterly results and bullish 2026 outlook have reignited investor interest, sparking a sharp rally. However, the microinverter leader's path forward is clouded by sector headwinds and a stark contrast between recent gains and steep annual losses.
Visa shares have retreated from recent highs, presenting a conundrum for investors. While its long-term track record remains stellar, short-term weakness and conflicting valuation signals demand a closer look at the payments giant's prospects.
The parent company of Titleist and FootJoy has seen its fair value estimate rise modestly to around $87, reflecting a cautious but growing confidence in its ability to meet expectations, even as some analysts warn the stock may be nearing fair price.
A coalition of major investors has filed resolutions challenging BP's pivot back toward oil and gas, demanding greater transparency on capital allocation and how the strategy aligns with earlier climate pledges ahead of the annual meeting.
As AutoZone's fair value estimate adjusts to around $4,210, a nuanced tug-of-war emerges on Wall Street. Analysts are fine-tuning models, balancing long-term operational confidence against near-term consumer spending concerns, reshaping the investment narrative for the auto parts retailer.
Analysts have nudged Teva Pharmaceutical's fair value estimate upward but tightened their valuation ranges, reflecting a guarded optimism as the company's pipeline developments through 2026 face scrutiny against a modest revenue growth forecast.
NGL Energy Partners (NGL) reported robust quarterly results, featuring record water disposal volumes and significant adjusted EBITDA growth. The partnership's units have surged over 20% in the past month, prompting investors to question if the stock still holds value after its impressive run.
Qualcomm is aggressively diversifying beyond its core smartphone business, forging key partnerships in Open RAN with Rakuten Mobile and 1Finity, launching an Asia-Pacific edge AI initiative, and securing a major automotive design win with ECARX. This strategic expansion signals a fundamental shift for the chipmaker as it aims to become a central player in next-generation infrastructure and intelligent systems.
PAR Technology's shares have plummeted over 68% in the past year, raising critical questions about its future. While a discounted cash flow model suggests deep undervaluation, other metrics paint a more complex picture. Investors are left weighing the stark disconnect between the company's software potential and its market performance.
Axsome Therapeutics' preliminary 2025 results reveal blockbuster-level sales for its depression drug Auvelity, while investor focus intensifies on its potential FDA label expansion for Alzheimer's disease agitation—a move that could redefine the company's valuation and pipeline prospects.
South Bow (TSX:SOBO) is walking a tightrope, balancing a lucrative dividend payout with an aggressive debt-reduction plan. With its flagship Blackrod Project nearing completion, the Calgary-based energy firm faces both opportunity and constraint in Western Canada's pipeline network.
A new analysis reveals the stark income gap facing working parents in the Washington, D.C. area, where the cost of childcare far outpaces typical household earnings, mirroring a national crisis.
Senator Tim Scott pushes back against a Justice Department investigation into Fed Chair Jerome Powell, calling it a political maneuver that is now jeopardizing the confirmation of President Trump's nominee to succeed Powell.
For retirees, neglecting to rebalance an investment portfolio is no longer a minor oversight—it's a critical risk that can amplify losses, deplete reserves, and permanently alter a retirement's trajectory. Behavioral biases and market momentum often conspire to create a dangerous imbalance between stocks and bonds, leaving savers exposed just when protection matters most.
Despite a recent 11% weekly slide, shares of Duos Technologies Group (NASDAQ: DUOT) have delivered a staggering 91% return to shareholders over the past three years, dramatically outperforming the broader market. The rally comes even as the company's revenue has contracted, highlighting a disconnect that has analysts urging caution.
